Cellebrite DI Ltd. (CLBT)
NASDAQ: CLBT · Real-Time Price · USD
19.86
+0.02 (0.10%)
May 12, 2025, 3:57 PM - Market open
Cellebrite DI Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Cellebrite DI stock have an average target of 23, with a low estimate of 17 and a high estimate of 28. The average target predicts an increase of 15.81% from the current stock price of 19.86.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Cellebrite DI stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 6 | 6 | 6 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $29 → $25 | Buy | Maintains | $29 → $25 | +25.88% | May 12, 2025 |
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +40.99% | Apr 2, 2025 |
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +40.99% | Mar 27, 2025 |
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +40.99% | Mar 10, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $17 → $26 | Strong Buy | Maintains | $17 → $26 | +30.92% | Feb 14, 2025 |
Financial Forecast
Revenue This Year
493.85M
from 401.20M
Increased by 23.09%
Revenue Next Year
580.81M
from 493.85M
Increased by 17.61%
EPS This Year
0.42
from -1.35
EPS Next Year
0.50
from 0.42
Increased by 17.59%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 512.4M | 615.3M | 731.9M | |
| Avg | 493.9M | 580.8M | 682.2M | |
| Low | 470.4M | 545.9M | 627.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 27.7% | 24.6% | 26.0% | |
| Avg | 23.1% | 17.6% | 17.5% | |
| Low | 17.2% | 10.5% | 8.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.49 | 0.59 | 0.72 | |
| Avg | 0.42 | 0.50 | 0.65 | |
| Low | 0.36 | 0.42 | 0.57 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | 38.5% | 45.1% | |
| Avg | - | 17.6% | 29.7% | |
| Low | - | -1.4% | 13.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.